Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | PPM1B | O75688 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL905284 | 1.00 | LMNA (0.58) | LMNAGAATSHRCNR1DAGLA | |
| SCHEMBL80480 | 1.00 | LMNA (0.58) | LMNAGAATSHRCNR1DAGLA | |
| Hydrochloric Acid SCHEMBL29400035 | 0.98 | LMNA (0.57) | LMNAGAATSHRCNR1DAGLA | |
| Pidolic Acid SCHEMBL14859342 | 0.94 | LMNA (0.53) | LMNAGAATSHRCNR1DAGLA | |
| Isopropyl Alcohol SCHEMBL28077462 | 0.94 | LMNA (0.53) | LMNAGAATSHRCNR1DAGLA | |
| SCHEMBL15265428 | 0.90 | LMNA (0.49) | LMNAGAATSHRALDH1A1MAPT | |
| SCHEMBL5992612 | 0.90 | LMNA (0.49) | LMNAGAATSHRALDH1A1MAPT | |
| SCHEMBL13106060 | 0.90 | LMNA (0.49) | LMNAGAATSHRALDH1A1MAPT | |
| SCHEMBL3066907 | 0.88 | LMNA (0.48) | LMNAGAATSHRALDH1A1MAPT | |
| SCHEMBL7381519 | 0.87 | LMNA (0.47) | LMNAGAATSHRALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 565 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121570433-A | Glutamine metabolism regulation nano drug delivery system for enhancing pancreatic cancer targeting and penetration, and preparation method and application thereof | 复旦大学 | 2026-02-27 | — | — | CN | claimed |
| EP-3947410-B1 | 3ALPHA, 5BETA-NEUROACTIVE STEROIDS FOR THE TREATMENT OF EPILEPSY AND SEIZURE DISEASES | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I (CZ) | 2025-02-12 | — | — | EP | claimed |
| CN-107343984-B | Method for manufacturing medical micro-needle patch | 怡定兴科技股份有限公司 | 2021-02-02 | — | — | CN | claimed |
| CN-110498762-A | One kind (2S, 5R) -5- [(benzyloxy) amino]-piperidines -2- Ethyl formate synthetic method | QILU TIANHE PHARMACEUTICAL CO LTD | 2019-11-26 | — | — | CN | claimed |
| WO-2019214838-A1 | USE OF AN ALCOHOL-CONTAINING COMPOSITION FOR IMPROVING THE SKIN BARRIER FUNCTION | EVIDERM INSTITUTE AB (SE) | 2019-11-14 | — | — | WO | claimed |
| CN-109965340-A | A kind of preparation method and application of Herba Cistanches extracting solution | 内蒙古昆明卷烟有限责任公司 | 2019-07-05 | — | — | CN | claimed |
| CN-109953367-A | A kind of Herba Cistanches extracting solution and preparation method thereof, composition and application | 内蒙古昆明卷烟有限责任公司 | 2019-07-02 | — | — | CN | claimed |
| CN-107383025-B | The preparation method of endocyclic compound | 吉林凯莱英医药化学有限公司 | 2019-04-26 | — | — | CN | claimed |
| CN-107383025-A | The preparation method of endocyclic compound | 吉林凯莱英医药化学有限公司 | 2017-11-24 | — | — | CN | claimed |
| US-20150094206-A1 | Biocide Compositions Comprising Derivatives Of Pyroglutamic Acid | COGNIS IP MAN GMBH (DE) | 2015-04-02 | — | — | US | claimed |
| CN-1222606-A | Water-disintegratable cleaning sheet containing alkylcellulose | UNI CHARM CORP (JP) | 1999-07-14 | — | — | CN | claimed |
| EP-0342056-B1 | Cosmetic composition | UNILEVER PLC (GB) | 1994-08-17 | — | — | EP | claimed |
| EP-0277428-B1 | Cosmetic composition | UNILEVER PLC (GB) | 1994-03-23 | — | — | EP | claimed |
| EP-0342055-B1 | Use of pyroglutamic acid alkyl esters for the manufacture of a medicament for the treatment of ichthyosis | UNILEVER PLC (GB) | 1994-01-12 | — | — | EP | claimed |
| EP-0342054-B1 | Cosmetic composition | UNILEVER PLC (GB) | 1993-11-03 | — | — | EP | claimed |
| US-5137714-A | Anhydrous cosmetic composition comprising stable lower alkyl esters of pyroglutamic acid | UNILEVER PATENT HOLDINGS B.V. (NL) | 1992-08-11 | — | — | US | claimed |
| EP-0342056-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1989-11-15 | — | — | EP | claimed |
| EP-0342054-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1989-11-15 | — | — | EP | claimed |
| EP-0342055-A2 | Use of pyroglutamic acid alkyl esters for the manufacture of a medicament for the treatment of ichthyosis | UNILEVER PLC (GB) | 1989-11-15 | — | — | EP | claimed |
| EP-0277428-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1988-08-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150094206-A1 | Biocide Compositions Comprising Derivatives Of Pyroglutamic Acid | GLUL, GLO1, PGD | LMNA 2726/4885GAA 59/4885TSHR 4785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.